L'Oreal USA: Drug Recall

Recall Details

Recall Number

D-0418-2025

Classification

Class II

Product Type

Drug

Recalling Firm

L'Oreal USA

Status

Ongoing

Date Initiated

03/05/2025

Location

Clark, NJ, United States

Voluntary/Mandated

Voluntary: Firm initiated

Product Quantity

14,460 bottles

Reason for Recall

cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.

Product Description

La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20 mL: UPC 883140035275) Tube, (benzoyl peroxide 0.5% and benzoyl peroxide 5.5% and salicylic acid 2%), La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France, UPC 883140035282 (kit).

Distribution Pattern

Nationwide in the USA

Other Recalls by L'Oreal USA

• Class II: Risk 03/05/2025
  cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
• Class II: Risk 03/05/2025
  Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

View all recalls by L'Oreal USA →